TRIB2 and colorectal carcinoma: found that knockdown of TUG1 inhibits tumor growth in vivo, where TUG1 interacts with miR-542-3p, affecting the expression of TRIB2 and inhibiting CRC proliferation through the Wnt/β-catenin pathway (198).